Impact of infectious disease consultation on the clinical and economic outcomes of solid organ transplant recipients admitted for infectious complications

Clinical Infectious Diseases

Volumn 59, Issue 8, 2014, Pages 1074-1082

  Hamandi, Bassem ^a,b   Husain, Shahid ^b   Humar, Atul ^b   Papadimitropoulos, Emmanuel A ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Costs; Infectious disease; Mortality; Organ transplant; Utilization

Indexed keywords

ADULT; ARTICLE; BACTERIAL PERITONITIS; BILIARY TRACT INFECTION; BLOODSTREAM INFECTION; CHRONIC KIDNEY FAILURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS INFECTION; DRUG COST; ECONOMIC EVALUATION; ESOPHAGUS CARCINOMA; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE UTILIZATION; HEART ARREST; HEART TRANSPLANTATION; HEPATITIS; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; INFECTIOUS COMPLICATION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVER TRANSPLANTATION; LUNG EMBOLISM; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; PROPENSITY SCORE; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SURVIVAL TIME; THERAPY DELAY; URINARY TRACT INFECTION; AGED; COMMUNICABLE DISEASES; HEALTH CARE COST; IMMUNOCOMPROMISED PATIENT; MORTALITY; SURVIVAL; TERTIARY CARE CENTER; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; COMMUNICABLE DISEASES; FEMALE; HEALTH CARE COSTS; HUMANS; IMMUNOCOMPROMISED HOST; LENGTH OF STAY; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; TRANSPLANT RECIPIENTS; TRANSPLANTS; TREATMENT OUTCOME;

EID: 84924404261     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu522     Document Type: Article

References (30)

1. Hamandi B, Holbrook AM, Humar A, et al. Delay of adequate empiric antibiotic therapy is associated with increased mortality among solidorgan transplant patients. Am J Transplant 2009; 9:1657-65.
2. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-14.
3. Hosseini-Moghaddam S, Husain S. Fungi and molds following lung transplantation. Semin Respir Crit Care Med 2010; 31:222-33.
4. Lupei MI, Mann HJ, Beilman GJ, Oancea C, Chipman JG. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate. Surg Infect 2010; 11:33-9.
5. Linden PK. Approach to the immunocompromised host with infection in the intensive care unit. Infect Dis Clin North Am 2009; 23: 535-56.
6. Cosgrove SE, Patel A, Song X, et al. Impact of different methods of feedback to clinicians after postprescription antimicrobial review based on the Centers for Disease Control and Prevention's 12 steps to prevent antimicrobial resistance among hospitalized adults. Infect Control Hosp Epidemiol 2007; 28:641-6.
7. Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009; 49:1175-84.
8. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:1000-8.
9. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010; 123:631-7.
10. Robinson JO, Pozzi-Langhi S, Phillips M, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012; 31:2421-8.
11. Pragman AA, Kuskowski MA, Abraham JM, Filice GA. Infectious disease consultation for Staphylococcus aureus bacteremia improves patient management and outcomes. Infect Dis Clin Pract 2012; 20:261-7.
12. Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010; 16:1783-8.
13. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-63.
14. Humar A, Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6:262-74.
15. Garner J, Jarvis W, Emori T, Horan T, Hughes J. CDC definitions for nosocomial infections, p. A1-A20. APIC infection control and applied epidemiology: principles and practice. St Louis, MO: Mosby, 1996.
16. Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med 2002; 137:693-5.
17. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-81.
18. Arpino B, Mealli F. The specification of the propensity score in multilevel observational studies. Comput Stat Data Anal 2011; 55:1770-80.
19. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46:399-424.
20. Zhang XD. Strictly standardized mean difference, standardized mean difference and classical t-test for the comparison of two groups. Stat Biopharm Res 2010; 2:292-9.
21. Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res 2000; 1:185-202.
22. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001; 20:461-94.
23. Ontario Case Costing Initiative. Ontario guide to case costing. Report No. Rev 7.0. Toronto: Ontario Ministry of Health and Long-Term Care, 2010.
24. Ontario Ministry of Health and Long-Term Care. Schedule of benefits for physician services under the health insurance act. Toronto: Ontario Ministry of Health and Long-Term Care, 2013.
25. Statistics Canada. Table 326-0021 consumer price index, health and personal care, by province (table). CANSIM (database). Available at: http://www5.statcan.gc.ca/cansim/a26?lang=eng&id=3260021&p2=17. Accessed 15 January 2014.
26. Schmitt S, McQuillen DP, Nahass R, et al. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis 2014; 58:22-8.
27. San Juan R, Aguado J, Lumbreras C, et al. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant 2007; 7:964-71.
28. Savitsky EA, Votey SR, Mebust DP, Schwartz E, Uner AB, McCain S. A descriptive analysis of 290 liver transplant patient visits to an emergency department. Acad Emerg Med 2000; 7:898-905.
29. Greenfield S, Nelson EC, Zubkoff M, et al. Variations in resource utilization among medical specialties and systems of care. Results from the medical outcomes study. JAMA 1992; 267:1624-30.
30. Classen DC, Burke JP, Wenzel RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997; 24:468-70.